Expression of aldo-keto reductase family 1 member b10 in the early stages of human hepatocarcinogenesis
about
Regulation of aldo-keto-reductase family 1 B10 by 14-3-3ε and their prognostic impact of hepatocellular carcinoma.Quantitative Proteomics Analysis of Tissue Interstitial Fluid for Identification of Novel Serum Candidate Diagnostic Marker for Hepatocellular Carcinoma.Identification and Validation of HCC-specific Gene Transcriptional Signature for Tumor Antigen Discovery.Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication.Antioxidant-rich leaf extract of Barringtonia racemosa significantly alters the in vitro expression of genes encoding enzymes that are involved in methylglyoxal degradation IIIPrognostic significance of AKR1B10 gene expression in hepatocellular carcinoma and surrounding non-tumorous liver tissue.Aldo-keto reductase family 1 member B10 is associated with hepatitis B virus-related hepatocellular carcinoma risk.Impact of aldo-keto reductase family 1 member B10 on the risk of hepatitis C virus-related hepatocellular carcinoma.Overexpression of NKX6.1 is closely associated with progressive features and predicts unfavorable prognosis in human primary hepatocellular carcinoma.Metabolomics reveals that aldose reductase activity due to AKR1B10 is upregulated in hepatitis C virus infection.Metallothionein 1M suppresses tumorigenesis in hepatocellular carcinoma.Pregnane X receptor activation and silencing promote steatosis of human hepatic cells by distinct lipogenic mechanisms.Potential of AKR1B10 as a Biomarker and Therapeutic Target in Type 2 Leprosy ReactionIntegrated analysis of the impact of age on genetic and clinical aspects of hepatocellular carcinoma
P2860
Q36629475-086F770C-41BD-4B29-9CC2-55500D7289ACQ36928906-534102CF-5715-478B-BF01-EAA3F0B696A2Q37076019-6B66C8C1-7E01-4199-8BC3-20EE95A7CADDQ37232717-15F66BD6-3EBA-48B4-B840-3AABA6E9FCD1Q37234146-7D10AB0E-B90A-43D7-A67E-56960C04F48AQ37582227-3D409389-FEF2-40DD-AEAD-FCECC959E23FQ40712186-99A19566-4C83-4E32-BD93-8C34914CBC17Q40835917-C92F81EA-C37C-4F77-9E57-2F626A4AE9B5Q41570382-01B4795C-5395-44B6-9F9E-C4F1B273B090Q41610203-E847DE43-6B6A-4AF6-8D40-972C3BBD45BCQ42212638-41D53D4E-47E8-4756-B2AF-1CE392E43308Q53023338-26BE3B50-3A7A-4BCC-A756-CC812101A8C2Q57492406-AFCE827A-24AB-4BA0-B473-5BADFFCA4EF0Q58733819-CA654EE2-893D-4184-9A5E-770575F83451
P2860
Expression of aldo-keto reductase family 1 member b10 in the early stages of human hepatocarcinogenesis
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Expression of aldo-keto reduct ...... of human hepatocarcinogenesis
@ast
Expression of aldo-keto reduct ...... of human hepatocarcinogenesis
@en
Expression of aldo-keto reduct ...... of human hepatocarcinogenesis.
@nl
type
label
Expression of aldo-keto reduct ...... of human hepatocarcinogenesis
@ast
Expression of aldo-keto reduct ...... of human hepatocarcinogenesis
@en
Expression of aldo-keto reduct ...... of human hepatocarcinogenesis.
@nl
prefLabel
Expression of aldo-keto reduct ...... of human hepatocarcinogenesis
@ast
Expression of aldo-keto reduct ...... of human hepatocarcinogenesis
@en
Expression of aldo-keto reduct ...... of human hepatocarcinogenesis.
@nl
P2093
P2860
P356
P1476
Expression of aldo-keto reduct ...... of human hepatocarcinogenesis
@en
P2093
Ayato Murata
Hironori Tsuzura
Katsuharu Hirano
Katsuyori Iijima
Masashi Mori
Sachiko Ishikawa
Shunsuke Sato
Takafumi Ichida
Takuya Genda
P2860
P304
P356
10.3390/IJMS15046556
P407
P577
2014-04-17T00:00:00Z